001     303953
005     20250821114622.0
024 7 _ |a 10.1093/jncimonographs/lgaf029
|2 doi
024 7 _ |a pmid:40828162
|2 pmid
024 7 _ |a 1052-6773
|2 ISSN
024 7 _ |a 1745-6614
|2 ISSN
037 _ _ |a DKFZ-2025-01728
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Zopf, Eva M
|0 0000-0001-6250-0041
|b 0
245 _ _ |a Considerations for delivery of live-remote exercise for people with cancer in research and practice.
260 _ _ |a Oxford
|c 2025
|b Oxford Univ. Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1755758258_3180
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Exercise is safe and beneficial for people diagnosed with cancer. The use of live-remote exercise approaches, where exercise trainers deliver exercise programs via a videoconferencing platform, has increased rapidly, greatly expanding the reach of exercise programs. This method retains key elements of supervised exercise, which provide greater benefits than unsupervised programs. However, challenges in adapting in-person supervised exercise programs to remote delivery exist. This article discusses the key considerations for the effective and safe delivery of live-remote exercise, such as technological requirements, exercise professional skills, safety aspects, exercise programming features, social interactions, costs, and legal and ethical considerations. Considerations relevant for the design and execution of exercise oncology clinical trials and for community practice are described. Remaining knowledge gaps are outlined and point to opportunities to further inform evidence-based practice and practice-based evidence.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Müller, Jana
|b 1
700 1 _ |a Trevaskis, Mark
|b 2
700 1 _ |a Kias, Alina
|0 P:(DE-He78)0b9996b44eae403b7cbb0fce2793e3c6
|b 3
|u dkfz
700 1 _ |a Hiensch, Anouk E
|b 4
700 1 _ |a Bland, Kelcey A
|b 5
700 1 _ |a Lorenz, Maria C
|b 6
700 1 _ |a Monninkhof, Evelyn M
|b 7
700 1 _ |a Schmidt, Martina E
|0 P:(DE-He78)2def8f8594c8f797f5ed4398258c6cac
|b 8
|u dkfz
700 1 _ |a Binyam, David
|b 9
700 1 _ |a Clauss, Dorothea
|0 P:(DE-He78)f52b77d7ab843c9b900134aafc61638a
|b 10
|u dkfz
700 1 _ |a Gunasekara, Nadira
|b 11
700 1 _ |a Crisafio, Mary
|b 12
700 1 _ |a De Jongh, Esther
|b 13
700 1 _ |a Olivier, Franziska
|b 14
700 1 _ |a Wengström, Yvonne
|b 15
700 1 _ |a Steindorf, Karen
|0 P:(DE-He78)a0c2037d9054be26907a05ae520d5756
|b 16
|u dkfz
700 1 _ |a Alves, Alberto J C
|b 17
700 1 _ |a Campbell, Anna
|b 18
700 1 _ |a Campbell, Kristin L
|b 19
700 1 _ |a Stuiver, Martijn M
|b 20
700 1 _ |a May, Anne M
|b 21
700 1 _ |a Winters-Stone, Kerri
|0 0000-0003-1706-8020
|b 22
773 _ _ |a 10.1093/jncimonographs/lgaf029
|g Vol. 2025, no. 71, p. 351 - 359
|0 PERI:(DE-600)2044141-1
|n 71
|p 351 - 359
|t Journal of the National Cancer Institute / Monographs
|v 2025
|y 2025
|x 1052-6773
909 C O |o oai:inrepo02.dkfz.de:303953
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)0b9996b44eae403b7cbb0fce2793e3c6
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-He78)2def8f8594c8f797f5ed4398258c6cac
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 P:(DE-He78)f52b77d7ab843c9b900134aafc61638a
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 16
|6 P:(DE-He78)a0c2037d9054be26907a05ae520d5756
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2025
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2024-12-12
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2024-12-12
920 1 _ |0 I:(DE-He78)C110-20160331
|k C110
|l Bewegung, Krebsprävention und Survivorship
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C110-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21